1. Expression of a Disintegrin and Metalloprotease 10 Gene Polymorphisms in a Cohort of Egyptian Patients with Hepatocellular Carcinoma
   Amal A. Mohamed et al, 2021, Current Cancer Therapy Reviews CrossRef
2. Clinical significance of ADAM10 expression in laryngeal carcinoma
   Bo You et al, 2017, Oncology Letters CrossRef
3. LncRNA H19 Regulates Proliferation, Apoptosis and ECM Degradation of Aortic Smooth Muscle Cells Via miR-1-3p/ADAM10 Axis in Thoracic Aortic Aneurysm
   Zhineng Fan et al, 2022, Biochemical Genetics CrossRef
4. Fine Tuning Cell Migration by a Disintegrin and Metalloproteinases
   D. Dreymueller et al, 2017, Mediators of Inflammation CrossRef
5. Insulin-like growth factor-1 activates different catalytic subunits p110 of PI3K in a cell-type-dependent manner to induce lipogenesis-dependent epithelial–mesenchymal transition through the regulation of ADAM10 and ADAM17
   Ga Bin Park et al, 2018, Molecular and Cellular Biochemistry CrossRef
6. “Amyloid‐beta accumulation cycle” as a prevention and/or therapy target for Alzheimer's disease
   Chinthalapally V. Rao et al, 2020, Aging Cell CrossRef
7. miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma
   Yahui Liu et al, 2017, Oncology Reports CrossRef
8. miR‑152 inhibits rheumatoid arthritis synovial fibroblast proliferation and induces apoptosis by targeting ADAM10
   Jialong Guo et al, 2018, International Journal of Molecular Medicine CrossRef
9. ADAM10 mediates malignant pleural mesothelioma invasiveness
   Christelle Sépult et al, 2019, Oncogene CrossRef
10. Overexpression of A disintegrin and metalloprotease 10 promotes tumor proliferation, migration and poor prognosis in hypopharyngeal squamous cell carcinoma
    Chuanjin Ding et al, 2017, Oncology Reports CrossRef
11. ADAM10 and ADAM17—Novel Players in Retinoblastoma Carcinogenesis
    Dario Van Meenen et al, 2022, International Journal of Molecular Sciences CrossRef
12. Effects of ADAM10 upregulation on progression, migration, and prognosis of nasopharyngeal carcinoma
    Bo You et al, 2015, Cancer Science CrossRef
13. Role of Some microRNA/ADAM Proteins Axes in Gastrointestinal Cancers as a Novel Biomarkers and Potential Therapeutic Targets—A Review
    Agnieszka Kalita et al, 2023, Current Issues in Molecular Biology CrossRef
14. Differential expression of “A Disintegrin and Metalloproteinase 10” in hepatocellular carcinoma and the noncancerous hepatic tissues: Contribution to HCV-promoted hepatocarcinogenesis
    AmalAbd El Hafez et al, 2023, Indian Journal of Pathology and Microbiology CrossRef
15. ADAM17 promotes cell migration and invasion through the integrin β1 pathway in hepatocellular carcinoma
    Yong Li et al, 2018, Experimental Cell Research CrossRef
16. 2-Deoxy-D-glucose suppresses the migration and reverses the drug resistance of colon cancer cells through ADAM expression regulation
    Ga B. Park et al, 2017, Anti-Cancer Drugs CrossRef
17. A novel role of HuR in ‐Epigallocatechin‐3‐gallate (EGCG) induces tumour cells apoptosis
    Wenxuan Jian et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
18. Search for useful biomarkers in hepatocellular carcinoma, tumor factors and background liver factors
    Dai Shimizu et al, 2017, Oncology Reports CrossRef
19. Novel therapeutic features of disulfiram against hepatocellular carcinoma cells with inhibitory effects on a disintegrin and metalloproteinase 10
    Kaku Goto et al, 2018, Oncotarget CrossRef
20. ADAM proteases: Emerging role and targeting of the non-catalytic domains
    Nayanendu Saha et al, 2019, Cancer Letters CrossRef
21. A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy
    Sooyeon Oh et al, 2020, Cancers CrossRef